Provided by Tiger Fintech (Singapore) Pte. Ltd.

GRAND PHARMA

8.990
+0.2703.10%
Volume:7.97M
Turnover:71.69M
Market Cap:31.91B
PE:12.75
High:9.110
Open:8.900
Low:8.890
Close:8.720
Loading ...

Grand Pharmaceutical Enrolls Patients in Eye Drop Phase 3 Clinical Trial

MT Newswires Live
·
04 Jun

Shanghai Bio-heart Launches New Kidney Treatment Device

MT Newswires Live
·
04 Jun

Grand Pharma's Demodex Blepharitis Treatment Approved in Macau; Shares Down 3%

MT Newswires Live
·
26 May

Grand Pharmaceutical Group Ltd. Announces Approval for Commercialization of Innovative Demodex Blepharitis Treatment by Macao ISAF of China

Reuters
·
25 May

Grand Pharmaceutical Gets China Radiation Safety License for Chengdu Nuclear Medicine Facility

MT Newswires Live
·
19 May

Grand Pharmaceutical Group Ltd. Obtains Class A "Radiation Safety License" for Nuclear Medicine R&D Base, Operations to Start in June

Reuters
·
18 May

Grand Pharmaceutical Gets China Nod for Phase 3 Studies of Prostate Cancer Drug

MT Newswires Live
·
08 May

BRIEF-Grand Pharmaceutical Says NMPA Accepts Application For Group's RDC TLX591

Reuters
·
07 May

Grand Pharmaceutical - Application for Group's Rdc Tlx591 to Join International Multicenter Phase Iii Clinical Trial Is Accepted by Nmpa

THOMSON REUTERS
·
07 May

the World's First: Grand Pharma's Global Innovative Product Stc3141 Successfully Reached the Clinical Endpoint in the Phase Ii Clinical Study in China

THOMSON REUTERS
·
07 May

Grand Pharmaceutical's Phase 2 Trial for Sepsis Drug Achieves Clinical Endpoints

MT Newswires Live
·
06 May

Grand Pharmaceutical's Hepatocellular Carcinoma Diagnosis Drug Exhibits Safety, Efficacy in Trial

MT Newswires Live
·
22 Apr

Grand Pharmaceutical Gets Registration Certificate for Nasal Spray in China

MT Newswires Live
·
22 Apr

BRIEF-Grand Pharmaceutical's Fluticasone Propionate Nasal Spray Approved For Commercialization in China

Reuters
·
22 Apr

Grand Pharmaceutical - Generic Fluticasone Propionate Nasal Spray in China Approved for Commercialization by Nmpa

THOMSON REUTERS
·
22 Apr

There's A Lot To Like About Grand Pharmaceutical Group's (HKG:512) Upcoming HK$0.26 Dividend

Simply Wall St.
·
09 Apr

Grand Pharma Group Doses First Patient in Tumor Drug Clinical Trial

MT Newswires Live
·
20 Mar

Grand Pharmaceutical Group Limited's (HKG:512) market cap increased by HK$3.5b, insiders receive a 49% cut

Simply Wall St.
·
14 Mar

Grand Pharmaceutical Group Divests 45% of Telix Pharmaceuticals Shares

MT Newswires Live
·
04 Mar

BRIEF-Grand Pharmaceutical Provides Update On Strategic Investment In Telix

Reuters
·
28 Feb